Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept
about
Advances in salivary gland gene therapy - oral and systemic implicationsCurrent and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases.Aquaporin gene therapy corrects Sjögren's syndrome phenotype in miceCausal variants in autoimmune disease: a commentary on a recent published fine-mapping algorithm analysis in genome-wide association studies study
P2860
Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting the splicing of mRNA ...... syndrome as a proof of concept
@en
Targeting the splicing of mRNA ...... yndrome as a proof of concept.
@nl
type
label
Targeting the splicing of mRNA ...... syndrome as a proof of concept
@en
Targeting the splicing of mRNA ...... yndrome as a proof of concept.
@nl
prefLabel
Targeting the splicing of mRNA ...... syndrome as a proof of concept
@en
Targeting the splicing of mRNA ...... yndrome as a proof of concept.
@nl
P2093
P2860
P356
P1433
P1476
Targeting the splicing of mRNA ...... syndrome as a proof of concept
@en
P2093
G Chiocchia
J A Chiorini
J L Vosters
N Roescher
X Mariette
P2860
P304
P356
10.1038/MT.2013.275
P577
2013-12-05T00:00:00Z